Literature DB >> 21199318

Percutaneous sacroplasty and sacroiliac joint cementation under fluoroscopic guidance for lower back pain related to sacral metastatic tumors with sacroiliac joint invasion.

Carlos Nebreda1, Ricardo Vallejo, Luis Aliaga, Ramsin Benyamin.   

Abstract

Cancer patients with bone metastases are at risk of a variety of skeletal events, including vertebral compression and pathologic fractures. Approximately 30% to 40% of patients with advanced lung cancer will develop bone metastases in the course of their disease, resulting in a significant negative impact on both morbidity and survival. Skeletal complications of bone metastases include pain, pathologic fractures, spinal cord compression, and hypercalcemia. The spine is the most frequent site of skeletal metastases. We present a 48-year-old female with intractable and incapacitating low back pain because of metastatic bone tumor in the left lateral side of S1 and S2 with left sacroiliac invasion. Imaging identified a metastatic invasion of the sacrum. Percutaneous sacroplasty, a safe and effective procedure for sacral-insufficient fractures, was performed under fluoroscopy guidance. However, the expected pain relief was not achieved. At 1 month, the patient remained invalided by severe back pain, which was localized to the left sacroiliac joint. In a second procedure, the sacroiliac joint was cemented. Pain relief was complete, immediate, and sustained until the patient's death related to the underlying oncologic disease. No complications were observed. Few reports exist about the treatment of sacral metastatic tumors with percutaneous sacroplasty. Further, no previous reports about sacroiliac joint cementation for joint stabilization have been found. In the present case, sacroiliac joint cementation successfully resolved residual pain that remained despite percutaneous sacroplasty treatment of the pathologic sacral fracture.
© 2011 The Authors. Pain Practice © 2011 World Institute of Pain.

Entities:  

Mesh:

Year:  2010        PMID: 21199318     DOI: 10.1111/j.1533-2500.2010.00439.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  5 in total

Review 1.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

2.  Safety and effectiveness of percutaneous sacroplasty: a single-centre experience in 58 consecutive patients with tumours or osteoporotic insufficient fractures treated under fluoroscopic guidance.

Authors:  Licia Pacheco Pereira; Frédéric Clarençon; Evelyne Cormier; Michèle Rose; Beatrix Jean; Lise Le Jean; Jacques Chiras
Journal:  Eur Radiol       Date:  2013-05-21       Impact factor: 5.315

3.  Clinical presentation, management and outcomes of sacral metastases: a multicenter, retrospective cohort study.

Authors:  Raphaële Charest-Morin; Charles G Fisher; Ann L Versteeg; Arjun Sahgal; Peter Pal Varga; Daniel M Sciubba; James M Schuster; Michael H Weber; Michelle J Clarke; Laurence D Rhines; Stefano Boriani; Chetan Bettegowda; Michael G Fehlings; Paul M Arnold; Ziya L Gokaslan; Nicolas Dea
Journal:  Ann Transl Med       Date:  2019-05

4.  CT-guided percutaneous bilateral sacroiliac joint arthroplasty.

Authors:  Gregory Johnston; Adrian Berg; Christopher S Morris
Journal:  Radiol Case Rep       Date:  2021-06-17

5.  Reconstruction With 3D-Printed Prostheses After Sacroiliac Joint Tumor Resection: A Retrospective Case-Control Study.

Authors:  Feifei Pu; Jianxiang Liu; Deyao Shi; Xin Huang; Jingtao Zhang; Baichuan Wang; Qiang Wu; Zhicai Zhang; Zengwu Shao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.